Mindimmune Therapeutics

Developing immunotherapeutics to restore neural connections in neurodegenerative diseases

placeLedyard, Connecticut, United States calendar_todayFounded 2016 groups7 employees language mindimmune.com

Registered entities

Social engagement

Social engagement: 1.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Slater Technology Fund, Dolby Family Ventures, Alzheimer's Drug Discovery, Trend-venture.com.

Investor typeCountShare
Venture capital450%
Other / undisclosed450%

Recent activity

1 Jul 2026
Event
Alzheimers Association International Conference (AAIC) 2026
24 Jun 2026
Event
BIO International Convention 2026
17 Jun 2026
Event
BIO 2026
Coming soon